All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

50

Reset

50 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • RetatrutideLY3437943Phase 316 trials

    Eli Lilly · Obesity, Overweight, Type 2 Diabetes

  • HL-1186Phase 36 trials

    Shanghai Yidian Pharmaceutical Technology Development Co., Ltd. · Postoperative Pain, Moderate to Severe Acute Postoperative Pain, Postherpetic Neuralgia ( PHN )

  • CebranopadolTRN-228Phase 34 trials

    Adneuris Therapeutics, Inc. · Pain, Acute Pain, Chronic Pain

  • EtoricoxibPhase 34 trials

    Laboratorios Silanes S.A. de C.V. · Gout Arthritis, Gout Attack, Acute Low-back Pain

  • MaltodextrinPhase 34 trials

    RDC Clinical Pty Ltd · Muscle Pain, Chronic Inflammation, Mobility

  • CPL-01local anaesthetic of CPL-01, Local anesthetic of CPL-01Phase 33 trials

    Cali Pharmaceuticals LLC · Bunion, Postoperative Pain, Hernia, Inguinal

  • HRS-2129Phase 33 trials

    Shandong Suncadia Medicine Co., Ltd. · Acute Gouty Arthritis, Postoperative Analgesia, Postoperative Pain in Orthopaedics

  • MaolactinPhase 33 trials

    RDC Clinical Pty Ltd · Muscle Pain, Chronic Inflammation, Mobility

  • Shanghai Haiyan Pharmaceutical Technology Co., Ltd. · Pain

  • DIPYRONEPhase 32 trials

    EMS · Moderate Pain, Severe Pain, Common Cold/Flu

  • Etoricoxib fixed doseEtoriPhase 32 trials

    Laboratorios Silanes S.A. de C.V. · Gout Arthritis, Gout Attack, Acute Low-back Pain

  • HSK21542Phase 32 trials

    Haisco Pharmaceutical Group Co., Ltd. · Postoperative Pain Management

  • matched to PregabalinPhase 32 trials

    Vertex Pharmaceuticals · Diabetic Peripheral Neuropathic Pain

  • matched to SUZPhase 32 trials

    Vertex Pharmaceuticals · Diabetic Peripheral Neuropathic Pain

  • NeridronatePhase 32 trials

    Ambros Therapeutics, Inc. · Complex Regional Pain Syndrome Type I

  • Remimazolam TosilatePhase 32 trials

    Jiangsu HengRui Medicine Co., Ltd. · Sedation in the ICU, Operative Sedation of Pediatric, Operative Sedation of Adolescent Patients

  • VER-01Phase 32 trials

    Vertanical GmbH · Lumbosacral Radiculopathy, Chronic Non-specific Low Back Pain

  • YJ001Phase 32 trials

    Zhejiang Hanmai Pharmaceutical Technology Co., Ltd. · Diabetic Peripheral Neuropathic Pain (DPNP)

  • CT001Phase 31 trial

    Cessatech A/S · Pain

  • DIT112Phase 31 trial

    EMS · Moderate Pain, Severe Pain

  • HCP1004Phase 31 trial

    Hanmi Pharmaceutical Company Limited · Chronic Low-back Pain

  • HSK16149Phase 31 trial

    Haisco Pharmaceutical Group Co., Ltd. · Central Neuropathic Pain

  • HSK3486Phase 31 trial

    Haisco Pharmaceutical Group Co., Ltd. · General Anesthetic

  • MR-107A-02Phase 31 trial

    Viatris Specialty LLC · Acute Pain, Post Operative Pain, Pain

  • PF614Phase 31 trial

    Ensysce Biosciences · Postoperative Pain, Acute

  • RLD2401Phase 31 trial

    Hanmi Pharmaceutical Company Limited · Chronic Low-back Pain

  • SL1002Phase 31 trial

    Saol Therapeutics Inc · Osteoarthritis Knee Pain

  • SP-102Phase 31 trial

    Semnur Pharmaceuticals, Inc. · Lumbosacral Radicular Pain

  • GenSci048Phase 23 trials

    Changchun GeneScience Pharmaceutical Co., Ltd. · Uveitis, Systemic Sclerosis Associated Interstitial Lung Disease, Rheumatoid Arthritis Associated Interstitial Lung Disease (RA-ILD)

  • LY4065967Phase 23 trials

    Eli Lilly · Chronic Pain, Diabetic Peripheral Neuropathic Pain, Osteoarthritis, Knee

  • TRD205Phase 23 trials

    Beijing Tide Pharmaceutical Co., Ltd · Postoperative Analgesia After Unilateral Hip Arthroplasty, Chronic Postoperative Neuralgia

  • AFA-281Phase 22 trials

    Afasci Inc · Alcohol Abuse, Alcohol Abuse/addiction, Anxiety

  • HSK55718Phase 22 trials

    Haisco Pharmaceutical Group Co., Ltd. · Pain After Surgery

  • matched to VX-993Phase 22 trials

    Vertex Pharmaceuticals · Diabetic Peripheral Neuropathic Pain, Acute Pain

  • TTAX03Phase 22 trials

    BioTissue Holdings, Inc · Knee Osteoarthritis, Knee Pain Chronic, Knee Arthritis

  • VNX001Phase 22 trials

    Vaneltix Pharma, Inc. · Interstitial Cystitis, Bladder Pain Syndrome

  • VX-993Phase 22 trials

    Vertex Pharmaceuticals · Diabetic Peripheral Neuropathic Pain, Acute Pain

  • ATX101Phase 21 trial

    Allay Therapeutics, Inc. · Total Knee Arthroplasty (Postoperative Pain)

  • CELZ-201-DDTPhase 21 trial

    Creative Medical Technology Holdings Inc · Chronic Low-back Pain, Degenerative Disc Disease

  • CYT-1010Phase 21 trial

    Cytogel Pharma, LLC · Acute Postoperative Pain, Dental Pain

  • GRT7040Phase 21 trial

    Grünenthal GmbH · Acute Pain, Bunionectomy

  • LTG-001Phase 21 trial

    Latigo Biotherapeutics · Acute Pain, Postoperative

  • LY3848575Phase 21 trial

    Eli Lilly · Neuropathic Pain, Distal Sensory Polyneuropathy

  • LY4515100Phase 21 trial

    Eli Lilly · Acute Pain, Molar, Molar, Third

  • MK-6916Phase 21 trial

    Merck & Co. · Pain Management

  • PP353Phase 21 trial

    Persica Pharmaceuticals Ltd · Chronic Low-back Pain

  • SRP-001Phase 21 trial

    South Rampart Pharma, Inc. · Acute Pain, Postoperative Pain, Pain

  • ST-01Phase 21 trial

    Sustained Therapeutics Inc. · Chronic Pain

  • VMD-3866Phase 21 trial

    VM Therapeutics LLC · Chemotherapy-induced Peripheral Neuropathy, Chemotherapy-induced Neuropathic Pain, CIPN - Chemotherapy-Induced Peripheral Neuropathy

  • YZJ-4729Phase 21 trial

    Shanghai Haiyan Pharmaceutical Technology Co., Ltd. · Pain

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.